Maturity-onset diabetes of the young: From a molecular basis perspective toward the clinical phenotype and proper management
Authors:
- Sofia Castro OliveiraSOSofia Castro Oliveira
- João Sérgio NevesJNJoão Sérgio Neves
- Antonio PérezAPAntonio Pérez
- Davide CarvalhoDCDavide Carvalho
- 1 February 2020
- journal article
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 67 (2) , 137-147
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Hidden MODY—Looking for a Needle in a HaystackFrontiers in Endocrinology, 2018
- Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future PerspectivesFrontiers in Endocrinology, 2018
- Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetesReviews in Endocrine and Metabolic Disorders, 2018
- Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize TreatmentCanadian Journal of Diabetes, 2016
- Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?Diabetes & Metabolism Journal, 2015
- MODYDiabetes Care, 2011
- Hepatocyte Nuclear Factor 4α Regulates the Expression of Pancreatic β-Cell Genes Implicated in Glucose Metabolism and Nutrient-induced Insulin SecretionJournal of Biological Chemistry, 2000
- The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolismProceedings of the National Academy of Sciences, 1997
- Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)Nature, 1996
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996